SE8204670D0 - Ny forening med antiulcerogen aktivitet, forfarande for dess framstellning och farmaceutisk beredning innehallande densamma - Google Patents

Ny forening med antiulcerogen aktivitet, forfarande for dess framstellning och farmaceutisk beredning innehallande densamma

Info

Publication number
SE8204670D0
SE8204670D0 SE8204670A SE8204670A SE8204670D0 SE 8204670 D0 SE8204670 D0 SE 8204670D0 SE 8204670 A SE8204670 A SE 8204670A SE 8204670 A SE8204670 A SE 8204670A SE 8204670 D0 SE8204670 D0 SE 8204670D0
Authority
SE
Sweden
Prior art keywords
preparation
activity
antiulcerogen
procedure
same
Prior art date
Application number
SE8204670A
Other languages
English (en)
Other versions
SE448456B (sv
SE8204670L (sv
Inventor
Vincentiis L De
Original Assignee
Ausonia Farma Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11208027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE8204670(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ausonia Farma Srl filed Critical Ausonia Farma Srl
Publication of SE8204670D0 publication Critical patent/SE8204670D0/sv
Publication of SE8204670L publication Critical patent/SE8204670L/sv
Publication of SE448456B publication Critical patent/SE448456B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/50—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/58—Radicals substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SE8204670A 1981-08-18 1982-08-12 N-(2-(((5-(dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioxibensyl)-2-nitro-1,1-etendiamin, forfarande for dess framstellning samt farmaceutisk beredning innehallande densamma SE448456B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23546/81A IT1168163B (it) 1981-08-18 1981-08-18 Composto ad attivita' antiulcera, procedimento per la sua preparazione e composizioni farmaceutiche relative

Publications (3)

Publication Number Publication Date
SE8204670D0 true SE8204670D0 (sv) 1982-08-12
SE8204670L SE8204670L (sv) 1983-02-19
SE448456B SE448456B (sv) 1987-02-23

Family

ID=11208027

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204670A SE448456B (sv) 1981-08-18 1982-08-12 N-(2-(((5-(dimetylamino)-metyl-2-furanyl)-metyl)-tio)-etyl)-n'-(3,4-metylendioxibensyl)-2-nitro-1,1-etendiamin, forfarande for dess framstellning samt farmaceutisk beredning innehallande densamma

Country Status (23)

Country Link
US (1) US4431664A (sv)
JP (1) JPS5859982A (sv)
KR (1) KR860000851B1 (sv)
AR (1) AR230444A1 (sv)
AT (1) AT383597B (sv)
AU (1) AU533719B2 (sv)
BE (1) BE894093A (sv)
CA (1) CA1182121A (sv)
CH (1) CH650259A5 (sv)
DE (1) DE3230265C2 (sv)
DK (1) DK156067C (sv)
ES (1) ES8306372A1 (sv)
FR (1) FR2511675A1 (sv)
GB (1) GB2104071B (sv)
GR (1) GR76260B (sv)
IT (1) IT1168163B (sv)
LU (1) LU84340A1 (sv)
NL (1) NL186447C (sv)
NO (1) NO159448C (sv)
PH (1) PH19228A (sv)
PT (1) PT75440B (sv)
SE (1) SE448456B (sv)
ZA (1) ZA825718B (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1175808B (it) * 1984-03-07 1987-07-15 Ausonia Farma Srl Procedimento per la preparazione di composto con attivita' antiulcera
IT1196133B (it) * 1984-06-06 1988-11-10 Ausonia Farma Srl Derivati furanici con attivita' antiulcera
KR950009825B1 (ko) * 1986-03-28 1995-08-29 자누스 화마스티씨 에스.알.엘. 치료학적 항궤양 활성이 있는 니페로티딘의 합성방법
GB8907700D0 (en) * 1989-04-05 1989-05-17 Fine Organics Ltd Preparation of substituted ethenes
JPH0416036U (sv) * 1990-05-31 1992-02-10

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140681A (en) * 1974-11-08 1979-02-20 Mitsubishi Chemical Industries, Limited N2 -Arylsulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof
US4233302A (en) * 1977-12-23 1980-11-11 Glaxo Group Limited Amine derivatives and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
GB2104071B (en) 1985-03-27
BE894093A (nl) 1982-12-01
FR2511675B1 (sv) 1984-02-10
AT383597B (de) 1987-07-27
CH650259A5 (it) 1985-07-15
DK156067C (da) 1989-12-04
CA1182121A (en) 1985-02-05
NL186447B (nl) 1990-07-02
IT1168163B (it) 1987-05-20
NO822801L (no) 1983-02-21
PT75440A (en) 1982-09-01
KR860000851B1 (ko) 1986-07-09
DK156067B (da) 1989-06-19
NO159448B (no) 1988-09-19
GR76260B (sv) 1984-08-04
AU8673182A (en) 1983-02-24
IT8123546A0 (it) 1981-08-18
AR230444A1 (es) 1984-04-30
SE448456B (sv) 1987-02-23
NL8203160A (nl) 1983-03-16
ES515068A0 (es) 1983-06-01
ATA312282A (de) 1986-12-15
FR2511675A1 (fr) 1983-02-25
LU84340A1 (fr) 1983-02-28
PH19228A (en) 1986-02-12
US4431664A (en) 1984-02-14
DE3230265C2 (de) 1984-09-20
AU533719B2 (en) 1983-12-08
SE8204670L (sv) 1983-02-19
KR840001162A (ko) 1984-03-28
DE3230265A1 (de) 1983-03-03
GB2104071A (en) 1983-03-02
NL186447C (nl) 1990-12-03
PT75440B (en) 1986-02-04
JPS6335631B2 (sv) 1988-07-15
NO159448C (no) 1988-12-28
ES8306372A1 (es) 1983-06-01
DK357182A (da) 1983-02-19
ZA825718B (en) 1983-06-29
JPS5859982A (ja) 1983-04-09

Similar Documents

Publication Publication Date Title
ES8601181A1 (es) Procedimiento de preparacion del 4 (2-(2-tenoil)-amino-3,5- dibromofenil)-metil-amino-ciclohexanol
ES514267A0 (es) "un procedimiento para la preparacion de derivados de pirrolidina".
SE8600413D0 (sv) Nytt lekemedel och sett att framstella detsamma
DK178883D0 (da) 2-(2'-hydroxy-3'-(1,1-dimethylpropylamino)-propoxy)-beta-phenylpropiophenon, syreadditionssalte deraf, fremgangsmade til fremstilling deraf samt farmaceutiske praeparater med indhold deraf
PT82512B (pt) Processo para a preparacao de derivados de quinolilglicinamidas com actividade psicotropica e de composicoes farmaceuticas que os contem
SE8204670L (sv) Ny forening med antiulcerogen aktivitet, forfarande for dess framstellning och farmaceutisk beredning innehallande densamma
SE8503055D0 (sv) Piperonylcarboxamido derivatives
ES2045067T3 (es) Procedimiento para preparar nuevos compuestos de tiazol.
AR230275A1 (es) Un procedimiento para la preparacion de n-(2-((5-dimetilamino)metil-2-furanilmetil)tio)etil)-n'-metil-2-nitro-1 1-etenodiamina(ranitidina)
NO840732L (no) Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n-(3-trifluormetylfenyl)-n`-propargylpiperazin
JPS5513285A (en) Imidazoline compound and medical composition
TR21596A (tr) Fungisid madde olarak yeni azolil-fenoksi-tetrahidrofuran-2-iliden metanlar
DE3068456D1 (en) 2-(n-(2-fluoro-6-bromophenyl)-n-(thiemyl-2-methyl)-amino)-2-imidazoline, its addition salts, pharmaceutical compositions containing them and processes for their preparation
JPS57108083A (en) 5-phenyltetrazole compound
ES523235A0 (es) "procedimiento para la preparacion de n-(2-(((5-(dimetilamino)-metil-2-furanil) metil) tio) etil) -n'- metil-2-nitro 1,1-etenodiamina"
ES497737A0 (es) Procedimiento para la obtencion de la n-(2-((5-((dimetilami-no)metil)furfuril)tio)etil)-n'- metil -2- nitro-1,1- eteno- diamina
IT1167489B (it) Procedimento per la preparazione della n-(2-(((5-(dimetilamino)-metil-2-furil)-metil)-tio)-)n'-metil-2-nitro-1,1-etilendiamina
ES543966A0 (es) Procedimiento para la preparacion de la n-(2-(((5-(dimetila-mino)-metil-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1- etendiamina
IT1169237B (it) Metodo per l'isolamento e la purificazione della n-(2-(((5-(dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-metil-2-nitro-1,1-etendiamina
IT1167794B (it) Procedimento per la preparazione del n-(2-(((5-(dimetilamino)-metil-2-furanil)-metil)-tio)-etil)-n'-metil-2-nitro-1,1 etendiamina
ES497386A0 (es) Procedimiento para la obtencion de la n-(2-( ( (5-( (dimeti-lamino)metil)-2-furanil)metil)tio)etil)-n'-metil-2-nitro-1,1-etenodiamina
JPS5573610A (en) Amphiblocking drug for alpha and beta receptors
IT1149947B (it) Procedimento di preparazione della n-(2-(((5-(dimetilamino)-metil-2-flranil)-metil)-tio)-etil)-n'-metil-2-nitro-1,1-etilendiamina
ES540987A0 (es) Un procedimiento para preparar n-(2-(((5-((dimetilamino)me- til)-2-furanil)metil)tio)etil)-n'-(3,4-metilendioxibencil)- 2-nitro-1,1-etenodiamina
IT1190660B (it) Composto ad attivita' mucoregolatrice e antitosse,procedimento per la sua preparazione e relative composizioni farmaceutiche

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8204670-7

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8204670-7

Format of ref document f/p: F